loader from loading.io

Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

JHLT: The Podcast

Release Date: 10/15/2025

Episode 83: Consensus on Graft Dysfunction within 72 Hours After Heart Transplant show art Episode 83: Consensus on Graft Dysfunction within 72 Hours After Heart Transplant

JHLT: The Podcast

JHLT: The Podcast starts May with an important ten-year update to a keystone document—the “.” The consensus summary—and a —appears in the May issue of JHLT, and is . The podcast is happy to host conference leader and first author Jon Kobashigawa, MD, Cedars-Sinai in Los Angeles, to talk about the consensus document, the conference, and PGD. The conversation includes discussion of: Why the document needed updating and how consensus was achieved The revised severity scale for PGD and the omission of the vasoactive-inotropic score Changes from the old document, including: Newer...

info_outline
Episode 82: JHLT Special Issue: Device Therapies show art Episode 82: JHLT Special Issue: Device Therapies

JHLT: The Podcast

In this episode, JHLT: The Podcast highlights a that’s just been released. The issue focuses on innovations in Device Therapies, and was edited by JHLT Deputy Editor Manreet Kanwar, MD, FACC, of the University of Chicago. Dr. Kanwar joins Digital Media Editor Van-Khue Ton, MD, PhD for a discussion about the special issue. The discussion explores: The importance of discussing device therapies in the advanced heart and lung failure communities The most anticipated device therapies in the pipeline for clinicians and patients to consider The impact of publishing in JHLT For the latest studies...

info_outline
Episode 81: Lung Cancer after Lung Transplant show art Episode 81: Lung Cancer after Lung Transplant

JHLT: The Podcast

JHLT: The Podcast kicks off April with a discussion of the paper, “,” which appears in the April issue of JHLT. Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper. The conversation includes discussion of: The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not Managing lung cancer in transplant recipients Immunosuppression in these patients, and other potential changes to clinical practice...

info_outline
Episode 80: Solid Organ Transplantation and HIV Infection show art Episode 80: Solid Organ Transplantation and HIV Infection

JHLT: The Podcast

JHLT: The Podcast continues a themed month on HIV infection in solid organ transplant, building on our last episode’s exploration from Dr. Saeed at Montefiore in New York. Our guest this episode is infectious diseases expert Cameron Wolfe, MD, Professor of Medicine at Duke University Medical Center. He joined us while on sabbatical with his family in Brisbane Australia for a conversation about how transplant centers now consider HIV infection, including transplant recipients who are HIV positive. The discussion explores: How the HOPE Act of 2013 changed practice in the United States,...

info_outline
Episode 79: Early Experience in Heart Transplantation Using Donors with HIV show art Episode 79: Early Experience in Heart Transplantation Using Donors with HIV

JHLT: The Podcast

This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, “,” which appears in the March issue of JHLT. First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode. The conversation includes discussion of: The ethics and evolution of the Montefiore program's transplant eligibility and criteria The role of the HOPE Act in the changes to the program Superinfection, viral strain analysis,...

info_outline
Episode 78: Barriers and Opportunities in DCD Heart Transplantation show art Episode 78: Barriers and Opportunities in DCD Heart Transplantation

JHLT: The Podcast

JHLT: The Podcast returns with an episode  for our heart transplant colleagues, discussing the paper, “,” from the February issue of JHLT. Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone. The discussion explores: Geographic variability on DCD heart utilization—why it happens and how to address Concerns around donor progression to circulatory arrest after life support withdrawal The volume of DCD hearts not utilized each...

info_outline
Episode 77: ISHLT Consensus Statement: Short Telomere Syndrome and Lung Transplantation show art Episode 77: ISHLT Consensus Statement: Short Telomere Syndrome and Lung Transplantation

JHLT: The Podcast

In this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on a new consensus statement from ISHLT on . The document was first published last month. They’re joined by document leads Andrew Courtwright, MD, PhD, of the University of Pennsylvania in Philadelphia; Dr. John Mackintosh of Prince Charles Hospital in Brisbane; and John McDyer, MD, of the University of Pittsburgh Medical Center in Pittsburgh. The conversation includes discussion of: Recommendations for assessing patients for STS Which patients we should screen How the diagnosis influences transplant decision...

info_outline
Episode 76: Evolocumab’s Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients show art Episode 76: Evolocumab’s Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients

JHLT: The Podcast

JHLT: The Podcast returns with an episode discussing the paper, “,” from the January issue of JHLT. Featured on this episode is early career guest host Bin Yang, MD, of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD, Dr. Yang shares hosting duties this episode and brings great questions to the discussion. Drs. Yang and Ton are joined by the first author, Salma Karim, and senior author, Hans Eiskjaer, both from Aarhus University Hospital in Denmark. The discussion explores: What imaging and physical markers the researchers used to determine if...

info_outline
Episode 75: A Look Back on 2025 in JHLT show art Episode 75: A Look Back on 2025 in JHLT

JHLT: The Podcast

Happy new year and welcome to a new season of JHLT: The Podcast! In this year-end recap, the Digital Media Editors will each share one of their favorite studies from The Journal of Heart and Lung Transplantation in 2025. You’ll get a look at some of the best science in advanced heart and lung failure from the past year.   Studies featured: Gomberg-Maitland M, et al. JHLT Apr 2025 44(4):609 – 624. Lefkowitz DS, et al. JHLT Apr 2025 44(4):487-502. Hollis P, et al. JHLT Dec 2025 44(12):1910-1917. Todurov B, et al. JHLT Nov 2025 44(11):1728-1734.   For the latest studies from...

info_outline
Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy show art Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

JHLT: The Podcast

JHLT: The Podcast returns with an episode discussing the paper, “,” from the December issue of JHLT.   They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.   The discussion explores: Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA) How APS patients differed from non-APS patients in the PEA cohort The changes in clinical practice at Marie Lannelongue...

info_outline
 
More Episodes

On this episode of JHLT: The Podcast, the Digital Media Editors invite co-lead author Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University.

Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, “Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis.”

The discussion explores:

  • Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs)
  • Why the study might show fewer SAEs than the literature historically shows
  • How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock
  • The ongoing and upcoming activities of CSWG

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.